Cardiovascular
New cardiovascular study findings recently were reported by researchers at University of Catania, Institute of Cardiology
Published in Drug Week, July 9th, 2010
A new study, 'Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registry,' is now available. According to a study from Catania, Italy, "Several studies showed that small vessel diameter is a determinant of increased risk of adverse events after stenting. The efficacy of different drug-eluting stent types implanted in small vessels has still not been established."
"The aim of the present observational study was to compare long-term clinical outcomes after sirolimus-eluting stent (SES) or paclitaxel-eluting stent (PES) implantation in lesions located in small coronary vessels. For the purpose of this analysis...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-07-09)
More Articles from Drug Week
- Clinical Trial Research
Biomoda Completes Patient Enrollment and Sample Collection in Pilot Study - BioMed Central
Danish children at risk from psychotropic medicines - Depression
Data on depression reported by researchers at University of South Australia - Drug Research
Findings from California State University, Department of Psychology provide new insights into drug research - Clozapine Therapy
Findings in clozapine therapy reported from R. Hanwella and co-researchers - Schizophrenia
Investigators at Hirosaki University, Medical Department target schizophrenia - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
